← Product Code [LIT](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/LIT) · K965183 # VANTAGE PERIPHERAL DILATATION CATHETER (K965183) _Guidant Corp. · LIT · Apr 24, 1997 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/LIT/K965183 ## Device Facts - **Applicant:** Guidant Corp. - **Product Code:** [LIT](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/LIT.md) - **Decision Date:** Apr 24, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1250 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Therapeutic ## Indications for Use The VANTAGE™ Peripheral Dilatation Catheter is intended for use in Percutaneous Transluminal Angioplasty (PTA) of the Iliac, Femoral, and Popliteal arteries. The VANTAGE™ Peripheral Dilatation Catheter is not intended for use in the coronary arteries or in neurovasculature. ## Device Story Double-lumen PTA balloon dilatation catheter; PET balloon bonded to shaft; balloon diameters 3-7 mm; shaft lengths 75-125 cm. Used by physicians in clinical settings for peripheral artery angioplasty. Device inflated to dilate stenotic vessels; improves blood flow. Mechanical operation; no software or electronic components. ## Clinical Evidence Bench testing only. Performed catheter preparation, balloon burst strength, compliance, inflation/deflation, fatigue, tip pull, bonding strength, body burst pressure, flow rate, and dimensional tests. Biocompatibility testing per Tripartite Guidelines and USP Class IV (cytotoxicity, sensitization, intracutaneous) passed. ## Technological Characteristics Double-lumen catheter; poly(ethylene)terephthalate (PET) balloon; 3-7 mm balloon diameter; 75-125 cm shaft length. Biocompatibility: USP Class IV plastics. Mechanical inflation/deflation. ## Regulatory Identification A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire. ## Predicate Devices - VANTAGE™ Dilatation Catheter ([K934433](/device/K934433.md)) - Ultra-thin™ Dilatation Catheter ([K920547](/device/K920547.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K965183 APR 24 1997 # SUMMARY OF SAFETY AND EFFECTIVENESS This 510 (k) summary of safety and effectiveness information is being submitted in accordance with the requirement of SMDA 1990. 1. **Submitted by** Advanced Cardiovascular Systems 3200 Lakeside Drive Santa Clara, CA 95052 2. **General Information** Device Name: VANTAGE™ Peripheral Dilatation Catheter- Additional Sizes Predicate Device: VANTAGE™ Dilatation Catheter (ACS) Ultra-thin™ Dilatation Catheter (Medi-Tech) Common Name: PTA Balloon Dilatation Catheter Device Classification: Class II 3. **Indications for Use** The VANTAGE™ Peripheral Dilatation Catheter is intended for use in Percutaneous Transluminal Angioplasty (PTA) of the Iliac, Femoral, and Popliteal arteries. The VANTAGE™ Peripheral Dilatation Catheter is not intended for use in the coronary arteries or in neurovasculature. 4. **Product Description** The 10 cm VANTAGE™ Peripheral Dilatation Catheter is a double-lumen catheter with a poly(ethylene)terephthalate (PET) balloon bonded to the shaft. The 10 cm VANTAGE™ Peripheral Dilatation Catheter has a range of balloon sizes from 3 mm to 7 mm in inflated diameter. The catheter is available in 75 cm to 125 cm shaft lengths. 5. **Rationale for Substantial Equivalence** The 10 cm VANTAGE™ Peripheral Dilatation Catheter is substantially equivalent to the ACS VANTAGE™ Dilatation Catheter (510 (k) Notification K934433) and Medi-Tech’s Ultra-thin™ Balloon Dilatation Catheter (510 (k) Notification K920547). The 10 cm VANTAGE™ Peripheral Dilatation Catheter is equivalent {1} to the VANTAGE™ and Ultra-thin™ Balloon Dilatation Catheters in term of its indications for use, functionality, performance and safety. The VANTAGE™ Dilatation Catheter and Ultra-thin™ Balloon Dilatation Catheter were found to be substantially equivalent to devices which were in commercial distribution prior to May 28, 1976. ## 6. Safety and Performance Studies The following tests were performed on the 10 cm VANTAGE™ Peripheral Dilatation Catheter: 1) Catheter Preparation Test 2) Balloon Minimum Burst Strength Test (Balloon Rupture) 3) Balloon Compliance Test (Distensibility) 4) Balloon Inflation/Deflation Tests 5) Balloon Fatigue Test (Repeated Balloon Inflation) 6) Tip Pulling Test 7) Bonding Strength Test 8) Catheter Body Burst Pressure Test 9) Contrast Medium Flow Rate Test 10) Dimensional Measurements (Tip Diameter and Profile Test) The results of each of the tests were found to be clinically acceptable. The 10 cm VANTAGE™ Peripheral Dilatation Catheter has been tested per the Tripartite Biocompatibility Guidelines and has passed the USP Class IV for plastics. The following biocompatibility tests were conducted: 1) Cytotoxicity - Elution 2) Sensitization 3) USP XXII Plastics Test (Class IV) - Intracutaneous Test The 10 cm VANTAGE™ Peripheral Dilatation Catheter passed each of the biocompatibility tests conducted. ## 7) Conclusions Based upon the indications for use, technological characteristics, and safety and performance studies, the 10 cm VANTAGE™ Peripheral Dilatation Catheter has been shown to be safe and effective for its intended use. --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/LIT/K965183](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/LIT/K965183) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com